Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-401.96%EBIT Margin
VS
Market
Sector
Industry
History
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information
Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSYNDAX PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SNDX - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -314.25M | -401.96% | $ 78.18M |
| 3/31/2025 | $ -318.28M | -727.96% | $ 43.72M |
| 12/31/2024 | $ -313.83M | -1325.29% | $ 23.68M |
| 9/30/2024 | $ -296.88M | -1855.47% | $ 16M |
| 6/30/2024 | $ -263.85M | -7538.54% | $ 3.5M |
| 3/31/2024 | $ -240.41M | 0% | $ 0 |
| 12/31/2023 | $ -209.15M | 0% | $ 0 |
| 9/30/2023 | $ -175.89M | 0% | $ 0 |
| 6/30/2023 | $ -158.47M | 0% | $ 0 |
| 3/31/2023 | $ -150.77M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT % stands at -4560.75%.
- Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average EBIT % has been -2380.02%.
- The median EBIT % for SYNDAX PHARMACEUTICALS INC during this period was -1026.63%
- SYNDAX PHARMACEUTICALS INC reached its highest EBIT % over the past 5 years at 19.2%.
- The lowest EBIT % recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe -7538.54%
SYNDAX PHARMACEUTICALS INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for SYNDAX PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -69.14M ] / Revenues [ $ 1.52M ]
(=) EBIT % [ -4560.75% ] SNDX - EBIT Margin, Last 5 years
-7538.54%
Minimum
Jun 30, 2024
19.2%
Maximum
Dec 31, 2021
-2380.02%
Average
-1026.63%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.54% |
| median | 9.01% |
| std | 23.96% |